ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Access to dermatologic care for cancer patients: employment of an oncodermatology referral system.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOncodermatology addresses skin conditions caused by cancer or its treatment, which can affect treatment decisions and quality of life. However, electronic health record (EHR)-related communication gaps and appointment wait times hinder timely care. This study assesses the effectiveness of an oncodermatology referral system implemented on March 1, 2023, within a large tertiary healthcare system.
methodsA centralized email listserv was created to enable oncologists to refer patients with skin complaints for timely care. A retrospective analysis was conducted on 466 patients referred from oncology to dermatology between September 1, 2022, and September 1, 2023. Patients were divided into three groups: Batch 1 (EHR referrals pre-implementation), Batch 2 (EHR referrals only post-implementation), and Batch 3 (all email listserv referrals post-implementation). Key outcomes measured include referral-to-scheduling time, referral-to-appointment time, proportion of underserved patients referred, zip code distribution of referred patients, and success rate of scheduling appointments post-referral.
resultsThere was a statistically significant increase in scheduled dermatology appointments post-implementation (Batch 1, 71%; Batch 2, 73%; Batch 3, 88%; P = .0008), as well as significant reductions in referral-to-scheduling (P = 9.82 × 10
conclusionA centralized email-based oncodermatology referral system significantly improved scheduling efficiency and access for underserved populations, underscoring the importance of streamlined referral processes in improving dermatologic care for cancer patients.
Indexed as
Identifiers
39915294What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.